Clinical implications of early ST-segment variability. A report from the ASSENT 2 St-monitoring sub-study

Coronary Artery Disease

Volumn 12, Issue 4, 2001, Pages 277-283

  Johanson, Per ^a   Svensson, Ann Marie ^a   Dellborg, Mikael ^a  

^a Sahlgrenska University Hopsital Östra   (Sweden)

Author keywords

Acute myocardial infarction; Electrocardiography; Prognosis; ST monitoring; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR; GLYCERYL TRINITRATE; STATIN; TENECTEPLASE; TICLOPIDINE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART RATE VARIABILITY; HEART REINFARCTION; HEMODYNAMIC MONITORING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVASCULARIZATION; ST SEGMENT ELEVATION;

AGED; ALGORITHMS; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; MALE; MYOCARDIAL INFARCTION; RECURRENCE;

EID: 0034971069     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200106000-00003     Document Type: Article

References (26)

1. Non-invasive detection of coronary artery patency using continuous ST-segment monitoring
2. Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction
3. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST-segment monitoring in the GUSTO-I trial
4. A simple electrocardiographic predictor of the outcome of patients with acure myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis
5. Prognostic information from on-line vectorcardiography in acute myocardial infarction
6. Extent of early ST-segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A sub-study of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial
7. Prognostic significance of ST-segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: The GUSTO-I ST-Segment Monitoring Sub study
8. Resolution of ST-segment elevation in acute myocardial infarction - Early prognostic significance after thrombolytic therapy. Results from the COBALT trial
9. Crinical value of 12-lead erectrocardiogram affer successful reperfusion therapy for acute myocardial infarction
10. Prognostic implications of TIMI fiow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Re-examining the "gold standard" for myocardial reperfusion assessment
11. Relative contributions of a singre-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease
12. Intermittent coronary occlusion in acure myocardial infarction. Value of combined thrombolytic and vasodilator therapy
13. Dynamic ORS and ST-segment changes in myocardial infarction monitored by continuous on-line vectorcardiography
14. The unstable ST-segment early after thrombolysis for acure infarction and its usefulness as a marker of recurrent coronary occlusion
15. Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for non-invasive patency assessment during acure myocardial infarction
16. ST-variability during the first four hours of acute myocardial infarction predicts one-year mortality
17. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial
18. Accurate, clinically practical system for spatial vectorcardiography
19. Infarct vessel status after intravenous tissue plasminogen activator and acure coronary angioplasty: Prediction of clinical outcome
20. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA
21. Newly identified tPA -7,351C/T polymorphism is associated with first-ever myocardial infarction
22. Impaired capacity for endogenous fibrinolysis in essential hypertension
23. Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expression
24. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic and less myocardial damage
25. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)
26. Circadian variation in the efficacy of tissue-type plasminogen activator